185 related articles for article (PubMed ID: 22411814)
41. Stable depletion of RUNX1-ETO in Kasumi-1 cells induces expression and enhanced proteolytic activity of Cathepsin G and Neutrophil Elastase.
Schoenherr C; Wohlan K; Dallmann I; Pich A; Hegermann J; Ganser A; Hilfiker-Kleiner D; Heidenreich O; Scherr M; Eder M
PLoS One; 2019; 14(12):e0225977. PubMed ID: 31826021
[TBL] [Abstract][Full Text] [Related]
42. Runx transcription factors in the development and function of the definitive hematopoietic system.
de Bruijn M; Dzierzak E
Blood; 2017 Apr; 129(15):2061-2069. PubMed ID: 28179276
[TBL] [Abstract][Full Text] [Related]
43. The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia.
Vangala RK; Heiss-Neumann MS; Rangatia JS; Singh SM; Schoch C; Tenen DG; Hiddemann W; Behre G
Blood; 2003 Jan; 101(1):270-7. PubMed ID: 12393465
[TBL] [Abstract][Full Text] [Related]
44. Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation.
Huang G; Shigesada K; Ito K; Wee HJ; Yokomizo T; Ito Y
EMBO J; 2001 Feb; 20(4):723-33. PubMed ID: 11179217
[TBL] [Abstract][Full Text] [Related]
45. Compatibility of RUNX1/ETO fusion protein modules driving CD34+ human progenitor cell expansion.
Chen-Wichmann L; Shvartsman M; Preiss C; Hockings C; Windisch R; Redondo Monte E; Leubolt G; Spiekermann K; Lausen J; Brendel C; Grez M; Greif PA; Wichmann C
Oncogene; 2019 Jan; 38(2):261-272. PubMed ID: 30093631
[TBL] [Abstract][Full Text] [Related]
46. E protein silencing by the leukemogenic AML1-ETO fusion protein.
Zhang J; Kalkum M; Yamamura S; Chait BT; Roeder RG
Science; 2004 Aug; 305(5688):1286-9. PubMed ID: 15333839
[TBL] [Abstract][Full Text] [Related]
47. The EBF transcription factor Collier directly promotes Drosophila blood cell progenitor maintenance independently of the niche.
Benmimoun B; Polesello C; Haenlin M; Waltzer L
Proc Natl Acad Sci U S A; 2015 Jul; 112(29):9052-7. PubMed ID: 26150488
[TBL] [Abstract][Full Text] [Related]
48. ETO, but not leukemogenic fusion protein AML1/ETO, augments RBP-Jkappa/SHARP-mediated repression of notch target genes.
Salat D; Liefke R; Wiedenmann J; Borggrefe T; Oswald F
Mol Cell Biol; 2008 May; 28(10):3502-12. PubMed ID: 18332109
[TBL] [Abstract][Full Text] [Related]
49. The ubiquitin ligase STUB1 regulates stability and activity of RUNX1 and RUNX1-RUNX1T1.
Yonezawa T; Takahashi H; Shikata S; Liu X; Tamura M; Asada S; Fukushima T; Fukuyama T; Tanaka Y; Sawasaki T; Kitamura T; Goyama S
J Biol Chem; 2017 Jul; 292(30):12528-12541. PubMed ID: 28536267
[TBL] [Abstract][Full Text] [Related]
50. The Friend of GATA proteins U-shaped, FOG-1, and FOG-2 function as negative regulators of blood, heart, and eye development in Drosophila.
Fossett N; Tevosian SG; Gajewski K; Zhang Q; Orkin SH; Schulz RA
Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7342-7. PubMed ID: 11404479
[TBL] [Abstract][Full Text] [Related]
51. A stable transcription factor complex nucleated by oligomeric AML1-ETO controls leukaemogenesis.
Sun XJ; Wang Z; Wang L; Jiang Y; Kost N; Soong TD; Chen WY; Tang Z; Nakadai T; Elemento O; Fischle W; Melnick A; Patel DJ; Nimer SD; Roeder RG
Nature; 2013 Aug; 500(7460):93-7. PubMed ID: 23812588
[TBL] [Abstract][Full Text] [Related]
52. Upregulation of CD200R1 in lineage-negative leukemic cells is characteristic of AML1-ETO-positive leukemia in mice.
Kagiyama Y; Kitaura J; Togami K; Uchida T; Inoue D; Matsukawa T; Izawa K; Kawabata KC; Komeno Y; Oki T; Nakahara F; Sato K; Aburatani H; Kitamura T
Int J Hematol; 2012 Nov; 96(5):638-48. PubMed ID: 23097187
[TBL] [Abstract][Full Text] [Related]
53. AML1-ETO targets and suppresses cathepsin G, a serine protease, which is able to degrade AML1-ETO in t(8;21) acute myeloid leukemia.
Jin W; Wu K; Li YZ; Yang WT; Zou B; Zhang F; Zhang J; Wang KK
Oncogene; 2013 Apr; 32(15):1978-87. PubMed ID: 22641217
[TBL] [Abstract][Full Text] [Related]
54. Transcriptional Auto-Regulation of RUNX1 P1 Promoter.
Martinez M; Hinojosa M; Trombly D; Morin V; Stein J; Stein G; Javed A; Gutierrez SE
PLoS One; 2016; 11(2):e0149119. PubMed ID: 26901859
[TBL] [Abstract][Full Text] [Related]
55. AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein.
Melnick A; Carlile GW; McConnell MJ; Polinger A; Hiebert SW; Licht JD
Blood; 2000 Dec; 96(12):3939-47. PubMed ID: 11090081
[TBL] [Abstract][Full Text] [Related]
56. Myeloid Leukemia Factor Acts in a Chaperone Complex to Regulate Transcription Factor Stability and Gene Expression.
Dyer JO; Dutta A; Gogol M; Weake VM; Dialynas G; Wu X; Seidel C; Zhang Y; Florens L; Washburn MP; Abmayr SM; Workman JL
J Mol Biol; 2017 Jun; 429(13):2093-2107. PubMed ID: 27984043
[TBL] [Abstract][Full Text] [Related]
57. Regulation of Drosophila friend of GATA gene, u-shaped, during hematopoiesis: a direct role for serpent and lozenge.
Muratoglu S; Garratt B; Hyman K; Gajewski K; Schulz RA; Fossett N
Dev Biol; 2006 Aug; 296(2):561-79. PubMed ID: 16730345
[TBL] [Abstract][Full Text] [Related]
58. Specification of Drosophila hematopoietic lineage by conserved transcription factors.
Lebestky T; Chang T; Hartenstein V; Banerjee U
Science; 2000 Apr; 288(5463):146-9. PubMed ID: 10753120
[TBL] [Abstract][Full Text] [Related]
59. Genetic compensation of RUNX family transcription factors in leukemia.
Kamikubo Y
Cancer Sci; 2018 Aug; 109(8):2358-2363. PubMed ID: 29883054
[TBL] [Abstract][Full Text] [Related]
60. Thrombopoietin/MPL participates in initiating and maintaining RUNX1-ETO acute myeloid leukemia via PI3K/AKT signaling.
Pulikkan JA; Madera D; Xue L; Bradley P; Landrette SF; Kuo YH; Abbas S; Zhu LJ; Valk P; Castilla LH
Blood; 2012 Jul; 120(4):868-79. PubMed ID: 22613795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
